Jiangsu, China

Jian Chen

This inventor holds 1 USPTO granted patent. Top assignee: Nantong Licheng Biological Engineering Co. Ltd. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Chen. Retrieved from https://idiyas.com/inventor/jian-chen-59iyotbo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jian Chen in Genetic Engineering

Introduction

Jian Chen is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of genetic engineering, particularly in the production of menaquinone 7 (MK-7). His innovative work has implications for various applications in biotechnology.

Latest Patents

Jian Chen holds a patent titled "Recombinant for increasing yield of menaquinone 7 and application thereof." This patent focuses on the development of recombinant strains that enhance the yield of MK-7. The research led to the construction of 14 recombinant strains, BS1-BS14, which significantly increased the yield of MK-7 to 33.5 mg/L, representing a 3.53 times increase over the original wild-type strain. This advancement provides a theoretical basis for creating high-yielding strains of MK-7.

Career Highlights

Jian Chen is associated with Nantong Licheng Biological Engineering Co. Ltd., where he continues to push the boundaries of genetic engineering. His work is characterized by a commitment to improving biotechnological processes and outcomes.

Collaborations

Jian Chen collaborates with talented individuals such as Hongzhi Xia and Long Liu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jian Chen's contributions to genetic engineering, particularly in enhancing the yield of menaquinone 7, highlight his role as a leading inventor in the field. His innovative approaches and collaborations continue to pave the way for advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…